When rats that can't make their own water-balancing hormone get a tiny dose of vasopressin through an IV, they pee less and their pee becomes more concentrated — showing the hormone still works to help their kidneys hold onto water.

What we've found so far is that vasopressin appears to reduce urine output and increase urine concentration in rats with impaired hypothalamic function. The evidence we’ve reviewed supports this effect, with no studies indicating otherwise. Our analysis of the available research shows that in rats unable to produce their own vasopressin due to blocked hypothalamic function, administering the hormone intravenously leads to decreased urine production and more concentrated urine [1]. This suggests that even when the brain’s normal signaling is disrupted, the kidneys can still respond to external vasopressin. The hormone’s role in helping the kidneys retain water seems to remain functional under these conditions [1]. We only reviewed one assertion, but it was strongly supported by 10.0 studies, with no conflicting evidence found. Still, our current analysis is based on a limited set of findings, and we cannot say how this might vary under different conditions or dosages. We also don’t have data on long-term effects or broader health impacts from the evidence provided. What this means is that, based on what we've seen so far, vasopressin can influence water balance in rats with hypothalamic disruption by reducing how much they urinate and making their urine more concentrated. The body’s response may depend on whether the kidneys are still able to react, even if the brain’s signal is missing. Practical takeaway: If the kidneys are working, replacing vasopressin may help control urine output in cases where the brain can’t signal properly — at least in rats.